Home > Insider Trading > Filing (0001209191-11-017823)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267602	Alimera Sciences Inc	ALIM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1489535	W. Calvin Roberts	6120 Windward Parkway Suite 290 Alpharetta GA 30005		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-25	7,600	$7.87	10,200	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2011-02-25	10,000	$7.95	10,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.809 to $7.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
The shares are held by The Lindsay Roberts Trust. Calvin Roberts is a Trustee of The Lindsay Roberts Trust. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The shares are held by The Joanna Roberts Trust. Calvin Roberts is a Trustee of The Joanna Roberts Trust. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.